Hyperfine receives additional $3.3 million grant to improve access to neonatal, pediatric brain imaging in low-resource settings
November 02, 2021
GUILFORD, Conn., Nov. 2, 2021 /PRNewswire/ -- Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced it received an additional $3.3 million grant from the Bill & Melinda Gates Foundation to expand the use of its portable MRI technology in developing countries. Based on promising early results from an initial $1.6 million grant, this new funding will extend a global research program that is currently assessing the clinical feasibility of the Hyperfine Swoop Portable MR Imaging System™ in providing immediate point-of-care (POC) brain imaging to young children between the ages of 0-24 months in low- and middle-income countries (LMIC).
The utilization of MRI technology to assess early brain development in children is critical to better understanding how to diagnose and manage birth asphyxia, sepsis, encephalitis, and meningitis, among many other neurological diseases and conditions. A total of 25 Swoop systems are being deployed across multiple research and clinical study sites in Europe, Asia, and Sub-Saharan Africa, to better understand the utility and applicability of low-field MR imaging to deliver accessible neuroimages that could provide an opportunity for early therapeutic intervention, and potentially become the standard of care, for infants and children during critical developmental stages.
"We are honored by the continued support of the Bill & Melinda Gates Foundation, which will help us expand our ability to push the boundaries of conventional imaging technology and improve patient access to accurate, timely diagnosis and care," said Dr. Khan Siddiqui, chief medical officer at Hyperfine. "The initial grant has already allowed us to gather important research, and we look forward to having an even greater impact with this investment as we continue expanding to new sites and geographies."
The ability to monitor early brain development plays a pivotal role in treating and minimizing the neurological damage incurred by malnutrition in children from LMIC. According to the World Health Organization, nearly half of all deaths in children under five years old are linked to nutrition-related factors. Malnutrition also contributes to long-term impacts on impoverished communities, such as education disparity, especially among females. Hyperfine, with support from the Bill & Melinda Gates Foundation, is working to break this vicious cycle in the developing world.
"This collaboration goes beyond improving healthcare systems in developing countries," said Dave Scott, president and CEO of Hyperfine. "By providing underserved communities with access to the care they need during the early critical stages of their lives, we hope to provide a brighter future for generations to come."
As part of the foundation's Maternal, Newborn & Child Health Discovery & Tools program, the investment is also establishing and coordinating a point-of-care (POC) MRI consortium to optimize the Hyperfine Swoop system with respect to image acquisition protocols and data quality for neonatal and infant brain imaging. This POC MRI consortium will generate and share data from a range of settings, including MRI research centers to develop and optimize sequences and neonatal and pediatric brain imaging clinical centers to evaluate data quality and information content relative to reference standard high-field MRI.
About Hyperfine and the Swoop Portable MR Imaging System
Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose and treat patients in various clinical settings. Swoop can be wheeled directly to the patient's bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments (ED), operating rooms (OR), and intensive care units (ICU), among others.